Royal Bank of Canada’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Royal Bank of Canada’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,997	Closed	-$34K	–	7849
2022 Q4	$34K	Sell	2,997 -82	-3%	-$795	﹤0.01%	6095
2022 Q3	$16K	Buy	3,079 +82	+3%	+$514	﹤0.01%	6247
2022 Q2	$12K	Sell	2,997 -682	-19%	-$3.88K	﹤0.01%	6336
2022 Q1	$42K	Sell	3,679 -1,553	-30%	-$18.5K	﹤0.01%	6208
2021 Q4	$95K	Buy	5,232 +581	+12%	+$7.37K	﹤0.01%	5989
2021 Q3	$55K	Buy	4,651 +2,882	+163%	+$42K	﹤0.01%	6110
2021 Q2	$31K	Buy	1,769 +327	+23%	+$6.22K	﹤0.01%	6332
2021 Q1	$27K	Buy	1,442 +288	+25%	+$6.04K	﹤0.01%	6269
2020 Q4	$22K	Buy	1,154 +142	+14%	+$3.06K	﹤0.01%	6027
2020 Q3	$21K	Buy	1,012 +95	+10%	+$2.22K	﹤0.01%	5689
2020 Q2	$26K	Buy	917 +886	+2,858%	+$26.7K	﹤0.01%	5485
2020 Q1	$1K	Sell	31 -614	-95%	-$19.9K	﹤0.01%	6548
2019 Q4	$16K	Buy	+645	New	+$11.3K	﹤0.01%	5970

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Royal Bank of Canada's OYST Position: Q1 2023 in Review

Royal Bank of Canada sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 2,997 shares — an estimated $34K sold.

Royal Bank of Canada first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $95K in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Royal Bank of Canada reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Royal Bank of Canada sold 2,997 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $34K.
Royal Bank of Canada first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
Royal Bank of Canada's Oyster Point Pharma, Inc. Common Stock position peaked at $95K in Q4 2021.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.